| OUR CUSTOMERS |
Want to know more about the research, applications and thoughts from other Q-Sense customers? Here you can read short testimonies and longer research articles written by our customers. Click on the statements below to read more. "Q-Sense has, by far, the most friendly and helpful customer service that we deal with on a regular basis" Read a short interview with Professor Rick Davis and his student Will Miles, at Chemical Engineering, Virginia Tech USA. “The QCM-D instrument was an obvious choice to assess the wet mass and composition of the lipid that we were using to create the membrane.” Read about Dr Lisa Martins electrochesistry combined QCM-D research at Monash University, Victoria, Australia. “It (QCM-D) also provides key information about the effects of solvent coupling that otherwise are difficult to access with other tools,” says Rojas. “Data interpretation may be challenging, but combined with other experimental approaches, it can be very useful and revealing.” Read about how Professor Rojas, at North Carolina State University, screen cellulase enzyme activity and test adsorption phenomena on thin film and how they test adsorption phenomena on films relevant to lignocellulosic and textil materials. “At Unilever we are interested in how surfactants work and their interaction with polymers. This is why QCM-D is an important part of our technical arsenal.” Read about Dr Jordan Petkov work at the R&D unit at Unilever, UK. “I guess everybody in the QCM-D community is well aware of the tremendous versatility of the flow chamber system for these studies” Read about Dr. Alex Welle, at the Institute for Biological Interfaces, Karlsruhe, Germany and his research on 3D scaffolds based on polymeric materials and stem cell development. “We have relied heavily on our QCM -D data to interpret the response of contacting liver cells…” and “We will continue to extensively use the QCM -D as these studies progress.” Read about Jennifer Phelps work at Yale University that could one day lead to the development of cell-based therapies for patients with compromised liver function.
|